Health Care Trends: Price Transparency Moves to the Forefront
Executive Summary
Price transparency is being touted as one of the chief tools to increase the quality and reduce the costs of health care. Although hospitals and physicians may have put up resistance to the price transparency movement at first, many are now either cooperating or preparing to cooperate with mandates for more disclosure on a variety of issues related to safety, performance, and comparisons with other providers. For the medical device community, the changes have been a reason to gauge how the evolving transformation might alter provider needs, but the whole transparency movement is poised to hit device manufacturers much closer to home than that.
You may also be interested in...
Health Care Trends: Cost Control Measures in Full Swing
Affordability drives medical devices purchases and use. Even the most remarkable devices can see a tremendous downturn in usage is reimbursement is lowered. That's why an an annoucement that CMS is considering changes to coverage of certain medical procedures is making device company CEOs more than a little nervous.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.